Actinic (Solar) Keratosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Actinic Solar Keratosis Clinical Trials Market Report Overview
The Actinic (Solar) Keratosis clinical trial market research report provides an overview of the Actinic (Solar) Keratosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Actinic (Solar) Keratosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Actinic (Solar) Keratosis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Actinic (Solar) Keratosis clinical trials market are North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa, among others. North America dominates the market.
In a country-wise analysis, as of November 2022, the US has the highest number of Actinic (Solar) Keratosis clinical trials, followed by Germany, Australia, Denmark, the UK, Italy, Austria, France, Spain, and Brazil.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Germany has the highest proportion of Actinic (Solar) Keratosis to Dermatology clinical trials as of November 2022. Moreover, the majority of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of Actinic (Solar) Keratosis to Dermatology clinical trials as of November 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in Brazil.
Actinic (Solar) Keratosis Clinical Trials Analysis by Regions
For more regional insights into the Actinic (Solar) Keratosis clinical trials market, download a free report sample
Actinic (Solar) Keratosis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Actinic (Solar) Keratosis clinical trials market are institution, company, and the government. Out of them, company dominates the market.
Actinic (Solar) Keratosis Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the Actinic (Solar) Keratosis clinical trials market, download a free report sample
Actinic (Solar) Keratosis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Actinic (Solar) Keratosis clinical trials market are LEO Foundation, Galderma SA, Almirall SA, Sun Pharmaceutical Industries Ltd, DermResearch Inc, Biofrontera AG, Viatris Inc, Graceway Pharmaceuticals LLC, TKL Research Inc, and AbbVie Inc. Out of them, LEO Foundation has conducted the highest number of Actinic (Solar) Keratosis clinical trials.
Actinic (Solar) Keratosis Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the Actinic (Solar) Keratosis clinical trials market, download a free report sample
Actinic (Solar) Keratosis Clinical Trials Market Report Overview
Key Regions | North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa |
Key Countries | The US, Germany, Australia, Denmark, the UK, Italy, Austria, France, Spain, and Brazil |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | LEO Foundation, Galderma SA, Almirall SA, Sun Pharmaceutical Industries Ltd, DermResearch Inc, Biofrontera AG, Viatris Inc, Graceway Pharmaceuticals LLC, TKL Research Inc, and AbbVie Inc |
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Galderma SA
Almirall SA
Sun Pharmaceutical Industries Ltd
DermResearch Inc
Biofrontera AG
Viatris Inc
Graceway Pharmaceuticals LLC
TKL Research Inc
AbbVie Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key regions in the Actinic (Solar) Keratosis clinical trials market?
The key regions in the Actinic (Solar) Keratosis clinical trials market are North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa, among others.
-
What are the key countries in the Actinic (Solar) Keratosis clinical trials market?
The key countries in the Actinic (Solar) Keratosis clinical trials market are the US, Germany, Australia, Denmark, the UK, Italy, Austria, France, Spain, and Brazil.
-
What are the key sponsor types in the Actinic (Solar) Keratosis clinical trials market?
The key sponsor types in the Actinic (Solar) Keratosis clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Actinic (Solar) Keratosis clinical trials market?
The leading sponsors in the Actinic (Solar) Keratosis clinical trials market are LEO Foundation, Galderma SA, Almirall SA, Sun Pharmaceutical Industries Ltd, DermResearch Inc, Biofrontera AG, Viatris Inc, Graceway Pharmaceuticals LLC, TKL Research Inc, and AbbVie Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.